Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |